Dr. Flynt received her Ph.D. in statistics from North Carolina State University.
For over thirteen years, she has worked in the pharmaceutical/biomedical industry for both a CRO and a pharmaceutical company where she has served as a lead statistician and provided statistical support for Phase 1-4 clinical trials, NDA submissions, and pharmaceutical industry-sponsored pregnancy registries. She has also provided FDA representation for her sponsors, served as a DMC statistician, and as a statistical consultant. Dr. Flynt joined PharPoint Research in its inaugural year to grow the biostatistics operations. Under her leadership, the PharPoint Research biostatistics group has grown 150%.